← Back to home

THE STUDY FOCUSED ON THE VASCULAR EFFECTS OF SEMAGLUTIDE IN BOTH DIABETIC AND NON-DIABETIC PATIENTS

Clinical trials for THE STUDY FOCUSED ON THE VASCULAR EFFECTS OF SEMAGLUTIDE IN BOTH DIABETIC AND NON-DIABETIC PATIENTS explained in plain language.

Never miss a new study

Get alerted when new THE STUDY FOCUSED ON THE VASCULAR EFFECTS OF SEMAGLUTIDE IN BOTH DIABETIC AND NON-DIABETIC PATIENTS trials appear

Sign up with your email to follow new studies for THE STUDY FOCUSED ON THE VASCULAR EFFECTS OF SEMAGLUTIDE IN BOTH DIABETIC AND NON-DIABETIC PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Heart drug tested for hidden vascular benefits

Disease control Completed

This study looked at whether the medication semaglutide improves blood flow through the heart's arteries in people with and without diabetes. Researchers measured blood flow in 122 patients before they started the drug and again three months later. The goal was to see if this com…

Matched conditions: THE STUDY FOCUSED ON THE VASCULAR EFFECTS OF SEMAGLUTIDE IN BOTH DIABETIC AND NON-DIABETIC PATIENTS

Sponsor: Ekrem Bilal Karaayvaz • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

THE STUDY FOCUSED ON THE VASCULAR EFFECTS OF SEMAGLUTIDE IN BOTH DIABETIC AND NON-DIABETIC PATIENTS

Get alerted when new THE STUDY FOCUSED ON THE VASCULAR EFFECTS OF SEMAGLUTIDE IN BOTH DIABETIC AND NON-DIABETIC PATIENTS trials appear

Heart drug tested for hidden vascular benefits